Abstract
This article describes the concept of probiotics for patients with irritable bowel syndrome to target functionally active bacteria predominantly belonging to the Clostridia and Bacteroidia, which play a key role in maintaining the balance of the gut microbiota.
| Original language | English |
|---|---|
| Article number | e14805 |
| Journal | Neurogastroenterology and Motility |
| Volume | 36 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - Aug 2024 |
Field of Science*
- 3.2 Clinical medicine
Publication Type*
- 1.1. Scientific article indexed in Web of Science and/or Scopus database